Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC34A1 | Q06495 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | FDPS | P14324 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 3/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA5A | P35218 | 2/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.32 |
| ▸ | TYMS | P04818 | 1/20 | 0.31 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL9506 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL5955535 | 0.95 | SLC34A1 (0.90) | SLC34A1LMNACA2KDM4ECYP2C19 | |
| Phosphoric Acid SCHEMBL18281498 | 0.95 | — | — | |
| Phosphoric Acid SCHEMBL3870317 | 0.95 | SLC34A1 (0.90) | SLC34A1LMNACA2KDM4ECYP2C19 | |
| Phosphoric Acid SCHEMBL138517 | 0.95 | — | — | |
| Phosphoric Acid SCHEMBL25433284 | 0.95 | — | — | |
| Phosphoric Acid SCHEMBL17459504 | 0.95 | SLC34A1 (0.90) | SLC34A1LMNACA2KDM4ECYP2C19 | |
| Phosphoric Acid SCHEMBL2954685 | 0.95 | SLC34A1 (0.90) | SLC34A1LMNACA2KDM4ECYP2C19 | |
| Phosphoric Acid SCHEMBL21357036 | 0.95 | — | — | |
| Phosphoric Acid SCHEMBL2236731 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116491610-A | Koi feed based on fermented peanut coat | 广西宇花灵科技发展有限公司 | 2023-07-28 | — | — | CN | claimed |
| CN-107158413-B | Nano metal oxide modified ultrasonic contrast agent and preparation method thereof | 华南理工大学 | 2020-05-22 | — | — | CN | claimed |
| CN-108034973-B | Direct electroplating hole metallization solution for printed circuit board and preparation method | 深圳市贝加电子材料有限公司 | 2020-04-28 | — | — | CN | claimed |
| CN-105420338-B | A kind of method that lipase fractionation DL- Valsartan ester prepares L- Valsartan | 天台宜生生化科技有限公司 | 2019-02-26 | — | — | CN | claimed |
| CN-108816056-A | A kind of preparation method of antipollution nanofiltration membrane | 佛山皖阳生物科技有限公司 | 2018-11-16 | — | — | CN | claimed |
| CN-107158413-A | A kind of nano-metal-oxide modification acoustic contrast agent and preparation method thereof | 华南理工大学 | 2017-09-15 | — | — | CN | claimed |
| CN-105420338-A | Method for preparing L-valsartan by decomposing DL-valsartan ester through lipase | TIANTAI YISHENG BIOCHEMISTRY TECH CO LTD | 2016-03-23 | — | — | CN | claimed |
| CN-105393759-A | High-yield planting method for Chinese herbal medicine Plantaginis semen | LI FENGLAN | 2016-03-16 | — | — | CN | claimed |
| EP-2152313-B1 | ORAL NICOTINE FORMULATION BUFFERED WITH AMINO ACID | MCNEIL AB (SE) | 2014-09-03 | — | — | EP | claimed |
| CN-102172412-A | Chemical indicator used for monitoring formaldehyde steam sterilization at low temperature and application | Tianjin kangdelai medical product co ltd | 2011-09-07 | — | — | CN | claimed |
| CN-1043450-A | The method of modifying of β zeolite | PETROLEUM CHEMICAL SCIENT ACAD (CN) | 1990-07-04 | — | — | CN | claimed |
| US-4254005-A | PERSULFATE POLYMERIZATION CATALYST, ALKALI METAL HYDROGEN PHOSPHATE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1981-03-03 | — | — | US | claimed |
| EP-4304364-B1 | DAIRY PRODUCT AND PROCESS | FONTERRA COOP GROUP LTD (NZ) | 2026-05-27 | — | — | EP | disclosed |
| US-20260014210-A1 | SYMBIOTIC BACTERIUM IN HUMANS FOR PROMOTING HAIR GROWTH AND USE THEREOF | SHANGHAI MICROH THERAPEUTICS LLC (CN) | 2026-01-15 | — | — | US | disclosed |
| US-20250228901-A1 | COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING INFLAMMATORY SKIN DISEASES, COMPRISING CUTIBACTERIUM SP. STRAIN | CJ BIOSCIENCE, INC. (KR) | 2025-07-17 | — | — | US | disclosed |
| US-12310382-B2 | Dairy product and process | FONTERRA CO-OPERATIVE GROUP LIMITED (NZ) | 2025-05-27 | — | — | US | disclosed |
| US-4698173-A | NONCORROSIVE; AMMONIUM CARBAMATE | HANSEN CHARLES N | 1987-10-06 | — | — | US | disclosed |
| US-4670261-A | REDUCING SUGAR, AMINO ACID(S) AND ELECTROLYTE | TANABE SEIYAKU CO., LTD. (JP) | 1987-06-02 | — | — | US | disclosed |
| EP-0176094-A1 | Parenteral alimentation solution | Tanabe Seiyaku Co., Ltd. (JP) | 1986-04-02 | — | — | EP | disclosed |
| EP-0168703-A2 | Reactive dyes | BAYER AG (DE) | 1986-01-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014210-A1 | SYMBIOTIC BACTERIUM IN HUMANS FOR PROMOTING HAIR GROWTH AND USE THEREOF | SHC1, SURF4, HGF | SLC34A1 290/4885LMNA 4753/4885CA2 3667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.